Literature DB >> 12142181

Long-term results after surgical correction of atrioventricular septal defects.

A Boening1, J Scheewe, K Heine, J Hedderich, D Regensburger, H-H Kramer, J Cremer.   

Abstract

OBJECTIVE: Review of the results of surgical correction of atrioventricular septal defects (AVSD), identification of risk factors for mortality and failure of left AV valve repair and determination of the impact of cleft closure on postoperative AV valve function.
METHODS: Between 1975 and 1995, 121 consecutive patients (55 males, 66 females) underwent surgery for biventricular correction of AVSD with a median age of 1.2 years and a median weight of 7.6 kg. Sixty-five patients had a complete AVSD, 17 patients an intermediate type, and 39 patients a partial AVSD. The left AV valve (MV) cleft was closed in 53 patients (43.8%). The mean follow-up time is 7.2+/-4.6 years.
RESULTS: Actuarial survival of the whole group after 1 year was 80%, after 10 and 20 years 78 and 65%, respectively. There were 18 early deaths (7-day mortality, 10.7%; 30-day mortality, 14.9%) and eight late deaths. In a univariate analysis, risk factors for early or late death were diagnosis of complete AVSD (P=0.006), no cleft closure (P=0.024), postoperative complications (P<0.0001), age <1.2 years (P=0.017), weight <7.6 kg (P=0.002), PA/Ao pressure ratio >0.7 (P<0.0001), and ECC time >110 min (P=0.002). In the multivariate analysis, postoperative complications (P=0.003) and PA/Ao pressure ratio >0.7 (P=0.001) had parallel effects on the postoperative risk for mortality. Moderate or severe MV regurgitation was present in six patients (6.0%) in the first evaluation after discharge and in 20 patients (20.4%) in the most recent postoperative control. There were 25 reoperations in 17 patients, of which 15 had to be performed for MV regurgitation and two for MV stenosis. Freedom from reoperation was 91% at 1 year, 79% at 10 years, and 76% at 15 and 20 years. We could not identify a statistically significant risk factor for reoperation.
CONCLUSIONS: In patients with AVSD of various morphologies closure of the left AV valve cleft significantly improves outcome without affecting the need for reoperation. Risk factors for early and late death (multivariate analysis) were a pulmonary/aortic pressure ratio >0.7 and the occurrence of any complication after surgery. The concept of an early surgical AVSD correction before an increase in pulmonary vascular resistance and AV valve deformations occur would represent a better surgical option than a late correction as done in our series. Early correction allows for reduction of early mortality, superior long-term survival rates and a high freedom from subsequent valve degeneration.

Entities:  

Mesh:

Year:  2002        PMID: 12142181     DOI: 10.1016/s1010-7940(02)00272-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  Atrioventricular septal defect prognosis for patients with Down syndrome.

Authors:  Marta Unolt; Carolina Putotto; Dario Marino
Journal:  Pediatr Cardiol       Date:  2012-08-25       Impact factor: 1.655

2.  Surgical interventions for atrioventricular septal defect subtypes: the pediatric heart network experience.

Authors:  Aditya K Kaza; Steven D Colan; James Jaggers; Minmin Lu; Andrew M Atz; Lynn A Sleeper; Brian W McCrindle; Linda M Lambert; Renee Margossian; Ronald V Lacro; Marc E Richmond; Shobha Natarajan; L Luann Minich
Journal:  Ann Thorac Surg       Date:  2011-08-26       Impact factor: 4.330

3.  Surgical Management for Complete Atrioventricular Septal Defects: A Systematic Review and Meta-Analysis.

Authors:  Yuhao Wu; Hongyu Kuang; Gang Wang; Jiangtao Dai; Yonggang Li; Guanghui Wei; Chun Wu
Journal:  Pediatr Cardiol       Date:  2020-06-24       Impact factor: 1.655

4.  Saddle arterial embolus in a patient with Down syndrome.

Authors:  U R Mohan; J S Mangat; N Sutaria; R C G Franklin
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

5.  Repair of complete atrioventricular septal defect in infants with down syndrome: outcomes and long-term results.

Authors:  Margarita R Tumanyan; Olga V Filaretova; Vera V Chechneva; Ruben S Gulasaryan; Iuliia V Butrim; Leo A Bockeria
Journal:  Pediatr Cardiol       Date:  2014-08-07       Impact factor: 1.655

6.  The Natural History of Atrioventricular Valve Regurgitation Throughout Fetal Life in Patients with Atrioventricular Canal Defects.

Authors:  Brooke T Davey; Jack Rychik
Journal:  Pediatr Cardiol       Date:  2015-08-04       Impact factor: 1.655

7.  Atrioventricular valve regurgitation in the fetus with atrioventricular canal defect: transition from prenatal to postnatal life.

Authors:  Brooke Davey; Deepika Thacker; Jack Rychik
Journal:  Pediatr Cardiol       Date:  2013-05-12       Impact factor: 1.655

Review 8.  Complete atrioventricular canal.

Authors:  Raffaele Calabrò; Giuseppe Limongelli
Journal:  Orphanet J Rare Dis       Date:  2006-04-05       Impact factor: 4.123

9.  Factors associated with moderate or severe left atrioventricular valve regurgitation within 30 days of repair of complete atrioventricular septal defect.

Authors:  Marcelo Felipe Kozak; Ana Carolina Leiroz Ferreira Botelho Maisano Kozak; Carlos Henrique De Marchi; Sirio Hassem Sobrinho Junior; Ulisses Alexandre Croti; Airton Camacho Moscardini
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

10.  Allelic Interaction between CRELD1 and VEGFA in the Pathogenesis of Cardiac Atrioventricular Septal Defects.

Authors:  Jennifer K Redig; Gameil T Fouad; Darcie Babcock; Benjamin Reshey; Eleanor Feingold; Roger H Reeves; Cheryl L Maslen
Journal:  AIMS Genet       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.